此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Improving Psychological Distress Among Critical Illness Survivors and Their Caregivers

2020年1月9日 更新者:Duke University
Patients who receive life support in intensive care units commonly suffer from persistent depression, anxiety, and post-traumatic stress disorder (PTSD) symptoms after discharge. We are trying to learn which is a better way to manage this distress: a telephone-based adaptive coping skills training program or an educational program.

研究概览

详细说明

Public Summary of Research Project Why is this important? Nearly 800,000 Americans receive mechanical ventilation for acute respiratory failure in the ICU each year. Afterward, over half of both patients and their family caregivers suffer from psychological distress (depression, anxiety, and post-traumatic stress ["PTSD"]) for over 1 year after discharge. Patients and families told us that they need help with their distress because it worsens their quality of life. More specifically, patients said that learning how to adapt (that is, how to cope) with the physical and emotional changes of critical illness would be helpful. In fact, most ICU survivors use coping skills infrequently, which worsens psychological distress. But patients also told us that they wanted more information about critical illness, recovery, and what to expect. A lack of information increases PTSD symptoms. However, there are few treatments for this distress that can overcome ICU survivors' physical disability, great distance from expert medical centers, and concerns about how much treatments would cost. Therefore, we developed two treatments to address coping and lack of information.

What is the main goal? We aim to compare which of two treatments are more effective in reducing psychological distress and improving quality of life. One is a coping skills training (CST) program provided by telephone. The other is an education program about critical illness that is accessed primarily online. Also, we will determine if unique groups of people with special characteristics have especially good improvement-and if so, what personal factors explain this response.

How will we know which treatment is better? We will determine which treatment is most helpful by comparing participants' levels of psychological distress and quality of life with surveys taken over 6 months. We'll also record patients' own descriptions of how the treatments impacted their daily lives. The study will take 3 years and would be performed at 5 medical centers across the US that treat patients with diverse backgrounds and illnesses. 200 ICU survivor-family member pairs will be randomly assigned (like a coin flip) to receive either the CST program or the education program. Treatments consist of 6 weekly telephone calls with a trained staff member, web-based modules, and handouts.

How will this help others in the future? This research is important because it aims to improve long-term recovery for entire families by focusing on a devastating, common, yet inadequately addressed problem. These treatments were developed with the direct input of patients and families. These treatments represent a new direction in treating critical illness because they can be delivered inexpensively by phone, easily adapted to future technologies, overcome barriers to care common to ICU survivors, and shared easily by phone or computer with others in need across the world.

研究类型

介入性

注册 (实际的)

417

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • North Carolina
      • Chapel Hill、North Carolina、美国、27599
        • University of North Carolina
      • Durham、North Carolina、美国、27710
        • Duke University
    • Pennsylvania
      • Pittsburgh、Pennsylvania、美国、15261
        • University of Pittsburgh
    • Washington
      • Seattle、Washington、美国、98195
        • University of Washington

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Patient inclusion criteria:

  • age >=18 and
  • mechanical ventilation for more than 48 consecutive hours

Patient exclusions (pre-consent):

  • current significant cognitive impairment (>=3 errors on the Callahan scale) or lacks decisional capacity
  • pre-existing significant cognitive impairment
  • residence at location other than home before hospital admission
  • need for a translator because of poor English fluency [many study instruments are not validated in other languages]
  • expected survival <3 months
  • discharged to hospice (outpatient or inpatient)
  • not liberated from mechanical ventilation at discharge

Additional patient exclusion criteria (present post-consent but pre-randomization):

  • Patients will become ineligible if they become too ill to participate
  • they develop significant cognitive disability, exhibit suicidality, they do not return home within 2 months after hospital discharge, or die.

Informal caregiver inclusion criteria:

  • age >=18 years
  • person most likely to provide the most post-discharge care.

Exclusions for caregivers are:

  • history of significant cognitive impairment
  • English fluency poor enough to require a medical translator

Informal caregiver exclusion criteria present after consent but before randomization:

  • no longer available
  • become too ill to participate
  • exhibit suicidality

A total of 200 patient-caregiver dyads (total cohort = 400) are targeted

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Coping skills training
6 sessions of weekly telephone-based coping skills training delivered by trained interventionist
6-session coping skills training program delivered by telephone w/ web augmentation
有源比较器:education program
6 week access to a web-based, critical illness-specific education program
web-based, ICU-specific education program

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Hospital Anxiety and Depression Scale Score
大体时间:3 & 6 months post-randomization
Hospital Anxiety and Depression Scale (HADS) questionnaire: The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale. The 3 month measure is primary outcome timing, though changes at 6 months will be tested as well
3 & 6 months post-randomization

次要结果测量

结果测量
措施说明
大体时间
Impact of Events Scale-revised (IES-R) Score
大体时间:3 & 6 months post-randomization
The IES-R evaluates subjective distress caused by traumatic events and assesses manifestations of post-traumatic stress disorder (PTSD) or acute stress disorder. It is not diagnostic but possesses excellent reliability and validity for manifestations of PTSD. The IES-R has three subscales (eight items on intrusion, eight items on avoidance, and six items on hyperarousal). Each item is scored on a four point scale: 0 = "not at all," 1 = "a little bit," 2 = "moderately often," 3 = "quite a bit," and 4 = "extremely often." The total score of each subscale may be averaged and a cumulative score of 30 is indicative of the presence of PTSD. The maximum score for each subscale is 32 for intrusion, 32 for avoidance, and 24 for hyperarousal. The minimum cumulative score is 0 and the maximum cumulative score possible is 88.3 months post-randomization is main time point while The 3 month IES-R score will be the primary analysis, though 6 month changes will be tested as well.
3 & 6 months post-randomization

其他结果措施

结果测量
措施说明
大体时间
Total Weeks at Home Post-randomization
大体时间:over 6 months follow up
here reported as weeks (instead of days) not at home for simplicity
over 6 months follow up

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2013年10月1日

初级完成 (实际的)

2016年2月1日

研究完成 (实际的)

2016年4月1日

研究注册日期

首次提交

2013年11月1日

首先提交符合 QC 标准的

2013年11月7日

首次发布 (估计)

2013年11月13日

研究记录更新

最后更新发布 (实际的)

2020年1月21日

上次提交的符合 QC 标准的更新

2020年1月9日

最后验证

2020年1月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • Pro00043171
  • PCORI PFA 195 (其他赠款/资助编号:PCORI PFA 195)

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅